Skip to content

Health— page 40

health

Australia’s Queensland confirms H5N1 bird flu case, fourth state

SYDNEY, July 25 (Reuters) – Queensland became Australia’s fourth state to confirm a case of H5N1 bird flu after authorities said on Saturday that a migratory seabird tested positive for ‌the highly pathogenic virus. Australia was the final continent to confirm a mainland case of H5N1 when the diseas

· SRN Health
health

Salmonella outbreak tied to eggs has sickened 98 people since November

WASHINGTON (AP) — Nearly 100 people in 17 states have been sickened in a salmonella outbreak tied to recalled eggs, federal health officials said Friday. The 98 people had illnesses that started between Nov. 21 and June 30, according to the U.S. Food and Drug Administration. No deaths have been repo

· SRN Health
Salmonella outbreak tied to eggs has sickened 98 people since November
health

Abbott defeats shareholder lawsuit over 2022 infant formula recall

By Jonathan Stempel July 24 (Reuters) – A federal judge on Friday dismissed a lawsuit accusing Abbott Laboratories of defrauding shareholders by downplaying and trying to evade its responsibility for a 2022 recall of powdered infant formula, and lying about its commitment to quality and product safe

· SRN Health
Abbott defeats shareholder lawsuit over 2022 infant formula recall
health

FDA advisory panel recommends peptide Semax be added to pharmacy compounding list

July 24 (Reuters) – A panel of advisers to the U.S. Food and Drug Administration on Friday voted to place a popular peptide called Semax on a list that would allow broader pharmacy compounding. Eight panel members voted in favor, while five voted against. One member abstained. The panel has backed f

· SRN Health
FDA advisory panel recommends peptide Semax be added to pharmacy compounding list
health

US FDA approves Outlook Therapeutics’ eye disease drug

July 24 (Reuters) – Outlook Therapeutics said on Friday the U.S. Food and Drug Administration has approved its drug for a type of eye disease that can cause vision loss. The New Jersey-based company was seeking approval for Lytenava to treat wet age-related macular degeneration (AMD), a chronic eye

· SRN Health
US FDA approves Outlook Therapeutics’ eye disease drug
health

Outbreak of diarrhea-causing parasite linked to 4 more states

WASHINGTON (AP) — Federal health officials on Friday expanded the scope of their investigation into an outbreak of a diarrhea-causing parasite to four additional states, broadening the size of the largest U.S. outbreak of cyclospora. The Centers for Disease Control and Prevention said the outbreak f

· SRN Health
Outbreak of diarrhea-causing parasite linked to 4 more states
health

US FDA approves over-the-counter Tylenol combination pill for pain relief

July 24 (Reuters) – The U.S. Food and Drug Administration on Friday approved a nonprescription, fixed-dose pill that combines Kenvue’s Tylenol with the nonsteroidal anti-inflammatory drug naproxen for up to 12 hours of pain relief. Here are some details: • The pill can be used by adults and children

· SRN Health
US FDA approves over-the-counter Tylenol combination pill for pain relief
health

US measles cases outpace 2025 record seven months into this year

By Mariam Sunny and Siddhi Mahatole July 24 (Reuters) – The United States has recorded 2,318 confirmed cases of measles so far this year, the CDC said on Friday, surpassing last year’s tally and marking the highest level since 1991. Of the total, 2,302 cases were reported by 45 jurisdictions and 16

· SRN Health
US measles cases outpace 2025 record seven months into this year
health

FDA panel votes to exclude peptide emideltide from pharmacy compounding list

July 24 (Reuters) – A panel of outside advisers to the U.S. FDA on Friday voted to exclude peptide emideltide from a list that would allow broader pharmacy compounding. Seven members voted against recommending emideltide to be on the list, while six members voted in favor. One member abstained. (Rep

· SRN Health
FDA panel votes to exclude peptide emideltide from pharmacy compounding list
health

Nearly 3,000 confirmed infected with Ebola in Congo after data review

July 24 (Reuters) – The number of people confirmed infected with Ebola in the Democratic Republic of Congo was heading towards 3,000 on Friday after officials reviewed data in two of the worst-hit provinces and reported more than 300 new cases. • The number of confirmed Ebola cases was 2,905, includ

· SRN Health
Nearly 3,000 confirmed infected with Ebola in Congo after data review
health

FDA advisers recommend relaxing US rules on compounding peptides

By Sriparna Roy, Sneha S K and Amina Niasse July 24 (Reuters) – Outside advisers to the U.S. Food and Drug Administration recommended broader access to six unapproved peptides, capping a two-day review that backed most of the compounds despite the health regulator’s staff concerns about limited safe

· SRN Health
FDA advisers recommend relaxing US rules on compounding peptides
health

Amgen submits new data to challenge FDA’s proposal to withdraw Tavneos

July 24 (Reuters) – Amgen said on Friday it submitted new evidence to the FDA on July 23 as it seeks a hearing to challenge the proposed withdrawal of its rare-disease drug Tavneos from the U.S. market. The U.S. Food and Drug Administration in April proposed withdrawing the drug, which treats a rare

· SRN Health
Amgen submits new data to challenge FDA’s proposal to withdraw Tavneos
health

Merck licenses experimental HIV pill to generic makers in 129 countries

By Christy Santhosh July 24 (Reuters) – Merck said on Friday it signed seven voluntary licensing agreements with generic drug manufacturers to make and sell lower-cost versions of its experimental once-monthly oral HIV pill in 129 low- and lower-middle-income countries. The drug, alimatravir, is cur

· SRN Health
Merck licenses experimental HIV pill to generic makers in 129 countries
health

India’s Manipal Health to spend $414.4 million to expand capacity

By Rishika Sadam and Vivek Kumar M July 24 (Reuters) – India’s Manipal Health Enterprises plans to spend 40 billion rupees ($414.38 million) to increase its bed capacity by over 18% in the next few years, a company executive said on Friday, ahead of the launch of the hospital chain operator’s IPO ne

· SRN Health
India’s Manipal Health to spend $414.4 million to expand capacity
health

AstraZeneca ‘magic’ faces rare test after trial failure, share slide

(Corrects name of rare neurological disorder, to ATTRv-PN, in paragraph 9) By Maggie Fick LONDON, July 24 (Reuters) – AstraZeneca’s long-time CEO Pascal Soriot has rarely put a foot wrong. The company’s shares have more that quadrupled in price during his 14-year tenure, soaring above the wider FTSE

· SRN Health
AstraZeneca ‘magic’ faces rare test after trial failure, share slide
health

Famine has ended in Gaza. But the gains are fragile and it could get worse

DEIR AL-BALAH, Gaza Strip (AP) — The world’s leading authority on food insecurity said Thursday that the situation in Gaza had improved since famine was declared in parts of the Palestinian territory last year, but warned that conditions are still at crisis levels. The Integrated Food Security Phase

· SRN Health
Famine has ended in Gaza. But the gains are fragile and it could get worse
health

Lettuce samples at Taylor Farms negative for cyclospora, Mexican authorities say

MEXICO CITY, July 23 (Reuters) – Mexico’s health ministry said on Thursday that results of its studies of lettuce and water samples from U.S. supplier Taylor Farms were negative for cyclospora, following a health inspection and the company’s plant in central Mexico earlier this week. “The analysis u

· SRN Health
Lettuce samples at Taylor Farms negative for cyclospora, Mexican authorities say
health

FDA advisory panel votes to place popular peptide TB-500 on compounding list

July 23 (Reuters) – A panel of advisers to the U.S. Food and Drug Administration on Thursday voted to place a popular peptide called TB-500 on a list that would allow broader pharmacy compounding. Eight panel members voted in favor, while six voted against. One member abstained. The FDA is not bound

· SRN Health
FDA advisory panel votes to place popular peptide TB-500 on compounding list
health

Edwards Lifesciences beats quarterly estimates on strong demand for heart devices

July 23 (Reuters) – Edwards Lifesciences beat analysts’ estimates for second-quarter profit and revenue on Thursday, helped by strong demand for its artificial heart valves used in complex cardiac procedures, sending its shares up nearly 7% in extended trading. Medical technology firms are seeing in

· SRN Health
health

GE HealthCare says CFO Saccaro to step down; reports preliminary Q2 results

July 23 (Reuters) – GE HealthCare’s Chief Financial Officer Jay Saccaro will step down from his role to pursue an opportunity outside the medical technology industry, the company said on Thursday, and also reported preliminary second-quarter results. The medical device maker named its current contro

· SRN Health
GE HealthCare says CFO Saccaro to step down; reports preliminary Q2 results
health

Senate committee postpones vote on whether to advance CDC director nominee

NEW YORK (AP) — The Senate health committee delayed a planned vote Thursday on whether to advance the nomination of Dr. Erica Schwartz to lead the U.S. Centers for Disease Control and Prevention. The committee plans to vote next week on whether to forward Schwartz’s nomination to the full Senate. Th

· SRN Health
Senate committee postpones vote on whether to advance CDC director nominee
health

FDA panel votes to place popular peptide BPC-157 on compounding list

July 23 (Reuters) – A panel of advisers to the U.S. Food and Drug Administration on Thursday voted to place a widely used peptide called BPC-157 on a list that would allow broader pharmacy compounding. Eight panel members voted in favor, while six members voted against it. One member abstained. (Rep

· SRN Health
FDA panel votes to place popular peptide BPC-157 on compounding list
health

FDA advisers back first of seven peptides under review for looser rules

By Sriparna Roy, Amina Niasse and Sneha S K July 23 (Reuters) – A majority of the U.S. Food and Drug Administration’s panel of outside advisers on Thursday voted to allow pharmacies to compound the first of seven in its review of widely used peptides, the increasingly popular compounded medicines ba

· SRN Health
FDA advisers back first of seven peptides under review for looser rules
health

Quest Diagnostics raises annual forecast on testing demand

July 23 (Reuters) – Quest Diagnostics on Thursday raised its full-year profit forecast, after demand for routine diagnostic testing helped the company beat second-quarter estimates. Shares of the ​New Jersey-based company rose about 5% in premarket trading following the results. Here are the details

· SRN Health